Glucocorticoid Therapy increases the cardiovascular Risk in RA Patients

被引：0
|
作者：
Di Lellis, Maddalena Angela
机构：
来源：
AKTUELLE RHEUMATOLOGIE | 2024年 / 49卷 / 04期
关键词：
D O I：
10.1055/a-2246-4107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The risk of cardiovascular events (CVE) in RA patients is increased by the use of glucocorticoids. Whether there is a threshold dose and maximum duration of corticoid use beyond which the CVE rate is increased is controversial. So et al. investigated the time-varying effect of glucocorticoids and their dose on the risk of major adverse cardiovascular events (MACE) in patients with RA.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Glucocorticoid-induced Cushing syndrome increases the risk of cardiovascular events
    Fiona Mitchell
    Nature Reviews Endocrinology, 2012, 8 (10) : 563 - 563
  • [2] Influence of infliximab on cardiovascular risk factors in patients with RA
    Nature Clinical Practice Rheumatology, 2009, 5 (2): : 64 - 64
  • [3] Dual ICI therapy increases risk of cardiovascular disorders
    Reactions Weekly, 2024, 2038 (1) : 5 - 5
  • [4] RA increases risk of CHD
    不详
    GERIATRICS, 2005, 60 (04) : 8 - 8
  • [5] Cardiovascular risk factor management in patients with RA compared to matched non-RA patients
    Alemao, Evo
    Cawston, Helene
    Bourhis, Francois
    Al, Maiwenn
    Rutten-van Moelken, Maureen P. M. H.
    Liao, Katherine P.
    Solomon, Daniel H.
    RHEUMATOLOGY, 2016, 55 (05) : 809 - 816
  • [6] Leflunomide increases the risk for incident peripheral neuropathies in patients with RA
    Strangfeld, Anja
    Kekow, Joern
    Krause, Andreas
    Bussmann, Arnold
    Hierse, Franka
    Listing, Joachim
    Zink, Angela
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S638 - S638
  • [7] Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?
    Buttgereit, F
    Burmester, G
    Bijlsma, JW
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) : 171 - 172
  • [8] Comparison of Cardiovascular Risk Factor Management in Patients with RA and Matched Non-RA Patients.
    Cawston, H.
    Alemao, E.
    Bourhis, F.
    Le, T.
    Al, M.
    Rutten-van Molken, M.
    Liao, K. P.
    Solomon, D. H.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S40 - S41
  • [9] Modifiable cardiovascular risk factors should be targeted in patients with RA
    Nature Clinical Practice Rheumatology, 2006, 2 (12): : 643 - 644
  • [10] Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
    Herman, Mary E.
    O'Keefe, James H.
    Bell, David S. H.
    Schwartz, Stanley S.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2017, 60 (03) : 422 - 434
12345